Anesthesia-A-Comprehensive-Review-Anesthesia-a-Comprehensive-Review

Anesthesia-A-Comprehensive-Review-Anesthesia-a-Comprehensive-Review

<p>Lead editor of <i>Braunwald’s Heart Disease</i>, Dr. Douglas L. Mann, and nationally and internationally recognized heart failure expert Dr. G. Michael Felker, bring you <b>the latest, definitive state-of-the art information on heart failure</b> in this outstanding <i>Braunwald’s</i> companion volume. <b>Heart Failure, 3rd Edition, keeps you current</b> with recent developments in the field, improved patient management strategies, and new drug therapies and implantable devices that will make a difference in your patients’ lives and in your practice. </p><ul><b><li>Consult this title on your favorite e-reader</b>, conduct rapid searches, and adjust font sizes for optimal readability.<U> </li></U><b> <p><li>Test your knowledge</b> of anesthesia through the most comprehensive, up-to-date coverage of basic science and clinical practice for an effective review. </li> <b> <p><li>Rely on trustworthy sources</b> and a <b>consistent level of difficulty</b> with questions vetted by Mayo residents. </li> </ul><ul> <ul><li><b>This edition includes 67 new authors, </b>who are experts in the field of heart failure<i><b> </b></li></i> <p><li><b>Stay on the cutting edge with new chapters on:</b></li> <ul> <p><li><b>The latest practice guidelines for medical and device therapy </b></li> <p><li><b>Hemodynamic assessment of heart failure</b></li> <p><li><b>Contemporary medical therapy for heart failure patients with reduced and preserved ejection fraction</b></li> <p><li><b>Biomarkers in heart failure </b></li> <p><li><b>Pulmonary hypertension</b></li> <p><li><b>Management of co-morbidities in heart failure</b></li> <p><li><b>Mechanical cardiac support devices</b></li> </ul> <p><li><b>Get up to speed with the latest clinical trials, </b>as well as how they have influenced current practice guidelines </li> <li><b>Explore what’s changing in key areas </b>such as basic mechanisms of heart failure, genetic screening, cell and gene therapies, pulmonary hypertension, heart failure prevention, co-morbid conditions, telemedicine/remote monitoring, and palliative care </li> </ul></ul> <p><b> </p></b>